These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


777 related items for PubMed ID: 10211533

  • 21. Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo.
    Entsuah AR, Huang H, Thase ME.
    J Clin Psychiatry; 2001 Nov; 62(11):869-77. PubMed ID: 11775046
    [Abstract] [Full Text] [Related]

  • 22. Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.
    Wang G, Gislum M, Filippov G, Montgomery S.
    Curr Med Res Opin; 2015 Apr; 31(4):785-94. PubMed ID: 25650503
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
    Sauer H, Huppertz-Helmhold S, Dierkes W.
    Pharmacopsychiatry; 2003 Sep; 36(5):169-75. PubMed ID: 14571350
    [Abstract] [Full Text] [Related]

  • 24. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
    Nemeroff CB, Entsuah R, Benattia I, Demitrack M, Sloan DM, Thase ME.
    Biol Psychiatry; 2008 Feb 15; 63(4):424-34. PubMed ID: 17888885
    [Abstract] [Full Text] [Related]

  • 25. Escitalopram versus venlafaxine XR in the treatment of depression.
    Montgomery SA, Andersen HF.
    Int Clin Psychopharmacol; 2006 Sep 15; 21(5):297-309. PubMed ID: 16877901
    [Abstract] [Full Text] [Related]

  • 26. A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
    Schatzberg A, Roose S.
    Am J Geriatr Psychiatry; 2006 Apr 15; 14(4):361-70. PubMed ID: 16582045
    [Abstract] [Full Text] [Related]

  • 27. Fluoxetine versus other types of pharmacotherapy for depression.
    Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C.
    Cochrane Database Syst Rev; 2005 Oct 19; (4):CD004185. PubMed ID: 16235353
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and tolerability of venlafaxine versus specific serotonin reuptake inhibitors in treatment of major depressive disorder: a meta-analysis of published studies.
    de Silva VA, Hanwella R.
    Int Clin Psychopharmacol; 2012 Jan 19; 27(1):8-16. PubMed ID: 21971532
    [Abstract] [Full Text] [Related]

  • 29. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
    Bielski RJ, Ventura D, Chang CC.
    J Clin Psychiatry; 2004 Sep 19; 65(9):1190-6. PubMed ID: 15367045
    [Abstract] [Full Text] [Related]

  • 30. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
    Thase ME, Entsuah AR, Rudolph RL.
    Br J Psychiatry; 2001 Mar 19; 178():234-41. PubMed ID: 11230034
    [Abstract] [Full Text] [Related]

  • 31. [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder].
    Agüera-Ortiz L, Ramos Garcia I.
    Actas Esp Psiquiatr; 2006 Mar 19; 34(3):153-61. PubMed ID: 16736388
    [Abstract] [Full Text] [Related]

  • 32. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    Rush AJ, Trivedi MH, Wisniewski SR, Stewart JW, Nierenberg AA, Thase ME, Ritz L, Biggs MM, Warden D, Luther JF, Shores-Wilson K, Niederehe G, Fava M, STAR*D Study Team.
    N Engl J Med; 2006 Mar 23; 354(12):1231-42. PubMed ID: 16554525
    [Abstract] [Full Text] [Related]

  • 33. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug 23; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM.
    J Clin Psychiatry; 1999 May 23; 60(5):326-35. PubMed ID: 10362442
    [Abstract] [Full Text] [Related]

  • 35. Randomized trial of sertraline versus venlafaxine XR in major depression: efficacy and discontinuation symptoms.
    Sir A, D'Souza RF, Uguz S, George T, Vahip S, Hopwood M, Martin AJ, Lam W, Burt T.
    J Clin Psychiatry; 2005 Oct 23; 66(10):1312-20. PubMed ID: 16259546
    [Abstract] [Full Text] [Related]

  • 36. The pharmacoeconomics of venlafaxine in depression.
    Morrow TJ.
    Am J Manag Care; 2001 Sep 23; 7(11 Suppl):S386-92. PubMed ID: 11570029
    [Abstract] [Full Text] [Related]

  • 37. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
    Gómez Gómez JM, Teixidó Perramón C.
    J Clin Psychiatry; 2000 Apr 23; 61(4):285-9. PubMed ID: 10830150
    [Abstract] [Full Text] [Related]

  • 38. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N, Maneeton B, Eurviriyanukul K, Srisurapanont M.
    Drug Des Devel Ther; 2013 Apr 23; 7():1053-62. PubMed ID: 24101861
    [Abstract] [Full Text] [Related]

  • 39. Achieving remission from depression with venlafaxine and venlafaxine extended release: a literature review of comparative studies with selective serotonin reuptake inhibitors.
    Rudolph RL.
    Acta Psychiatr Scand Suppl; 2002 Apr 23; (415):24-30. PubMed ID: 12492770
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatients.
    Feighner JP, Entsuah AR, McPherson MK.
    J Affect Disord; 1998 Jan 23; 47(1-3):55-62. PubMed ID: 9476744
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 39.